DUSP9 and metabolic dysfunction-associated steatohepatitis: In agreement with the two previous studies, Ye and collaborators reported the protective effect of the ectopic expression of DUSP9 against nonalcoholic steatohepatitis (NASH), the most frequent and pathophysiological form of NAFLD [34].